Evidence map›Paper›PMID 37835804›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections.

Emery Haley, Natalie Luke, Howard Korman, David Baunoch, Dakun Wang, Xinhua Zhao, Mohit Mathur

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emery HaleyDepartment of Clinical Research, Pathnostics, Irvine, CA 92618, USA.ORCID 0000-0002-4497-7601
Natalie LukeDepartment of Clinical Research, Pathnostics, Irvine, CA 92618, USA.
Howard KormanDepartment of Urology, Comprehensive Urology-A Division of Michigan Healthcare Professionals, Royal Oak, MI 48073, USA.
David BaunochDepartment of Research and Development, Pathnostics, Irvine, CA 92618, USA.
Dakun WangDepartment of Scientific Writing, Stat4Ward, Pittsburgh, PA 15238, USA.
Xinhua ZhaoDepartment of Statistical Analysis, Stat4Ward, Pittsburgh, PA 15238, USA.
Mohit MathurDepartment of Medical Affairs, Pathnostics, Irvine, CA 92618, USA.

Funding

CSRD VA 1
6 · The paper itself

Abstract

This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (

Indexed as

complicated UTI (cUTI)multiplex polymerase chain reaction (M-PCR)pooled antibiotic susceptibility testing (P-AST)recurrent UTI (rUTI)standard urine culture (SUC)urinary tract infection (UTI)UTI-related outcomesUTI treatment outcomes

Identifiers

PMID37835804
PMCPMC10573050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.